Search

everythinglearnresearchcommunity

for

Search:↓

Oral dutasteride is a recommended first treatment for frontal fibrosing alopecia.

The finasteride patch effectively treats hair loss by enhancing skin absorption.

Finasteride reduces PSA levels by around 40-50% in BPH patients.

Long-term use of finasteride and dutasteride can cause serious health issues like diabetes and liver problems.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Topical minoxidil and anthralin work for patchy alopecia areata but not for alopecia totalis/universalis.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Dutasteride effectively and safely treats male hair loss for over a year.

Finasteride can cause recurrent mouth ulcers.

DHA-NLC may improve drug delivery and reduce side effects for cancer treatment.

The FDA rejected a testosterone drug again due to safety concerns.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Dutasteride helps reduce heavy drinking, especially for those who drink to cope.

Both azathioprine and betamethasone treatments help with hair regrowth in alopecia areata, but azathioprine may have fewer side effects.

Stilbamidine and hydroxystilbamidine inhibit enzyme release from lysosomes and have effects similar to cortisol and chloroquine.

Combined finasteride and anastrozole therapy effectively treats BPH, influenced by hormone imbalances and genetics.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Finasteride may help treat BPH by affecting certain biological markers.

Oral minoxidil may slow male pattern baldness and cause body hair growth, but hair loss can happen after stopping it.

Ebastine may help regrow hair in alopecia areata patients.

Minoxidil can cause pericardial and pleural effusions with high protein content.

Apremilast may help treat hair loss in alopecia areata.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Finasteride may help improve certain brain function issues linked to dopamine.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.